Search Results 1921-1930 of 11949 for alcohol menopause

  1. Senior sex: Tips for older men - Mayo Clinic

    Tell your healthcare professional about any tobacco, alcohol or illicit drug use, as these may affect your sexual health. See a sex therapist. A therapist ...

  2. Recurrent Cancer Clinical Trials - Mayo Clinic Research

    The main purpose of this study is to evaluate how effective nonsteroidal aromatase inhibitors (NSAI) plus abemaciclib are in postmenopausal women with breast ...

  3. Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer - Mayo Clinic

    Known clinically significant liver disease, including active viral, alcoholic, or other hepatitis; cirrhosis; fatty liver; and inherited liver disease. Note ...

  4. Women's Wellness: Vaginal microbes and endometrial cancer - Mayo Clinic News Network

    Mayo Clinic Minute: Alcohol and cancer risk. Transplant. Mayo Clinic Minute: How alcohol affects your liver · About the News Network · Newsbureau@mayo.edu.

  5. A Study to Evaluate Pembrolizumab for Surgically Treated Adjuvant Merkel Cell Carcinoma - Mayo Clinic

    has not been naturally postmenopausal (amenorrhea following cancer therapy does not rule out childbearing potential) for at least 24 consecutive months ...

  6. Mayo Clinic Q and A: Testosterone therapy? Maybe

    ... alcohol use. Some medications may cause testosterone levels to drop, as well. As part of your evaluation, your doctor should review your current medications ...

  7. Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia - Mayo Clinic

    ... postmenopausal for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months); Men who have a female partner of ...

  8. Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer - Mayo Clinic

    Female patients are either postmenopausal for at least 1 year, are surgically sterile for at least 6 weeks, or must agree to take appropriate precautions to ...

  9. A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis - Mayo Clinic

    Known or suspected of not being able to comply with the study protocol (e.g., because of alcoholism, drug dependency, or psychological disorder) or the ...

  10. Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy - Mayo Clinic

    Has not been naturally postmenopausal for at least 12 consecutive months (i.e., has had menses at any time in the preceding 12 consecutive months). -Provide ...